Spotlight Asset Group’s Relmada Therapeutics RLMD Stock Holding History

Spotlight Asset Group’s Portfolio RLMD Stock Details RLMD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$60K	Hold
2024 Q1	$93K	Hold
2023 Q4	$60K	Hold
2023 Q3	$60K	Hold
2023 Q2	$49.2K	Hold
2023 Q1	$140K	Buy
2022 Q3	$140K	Buy
2021 Q3	$793K	Hold
2021 Q2	$969K	Buy
2021 Q1	$865K	Buy
2020 Q4	$728K	Buy